Candidemia in intensive care unit patients: Risk factors for mortality

Infection

Volumn 25, Issue 1, 1997, Pages 8-11

  Voss, A ^a   Le Noble, J L M L ^b   Verduyn Lunel, F M ^b   Foudraine, N A ^b   Meis, J F G M ^a  

^{a *}  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANCER; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INTENSIVE CARE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; RISK FACTOR; SEPTICEMIA; STEROID THERAPY; VEIN CATHETERIZATION;

CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031028323     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02113499     Document Type: Article

References (21)

1. Trilla, A.: Epidemiology and nosocomial infections in adult intensive care units. Intens. Care Med. 20 (Suppl. 3) (1994) S1-S4.
2. Martin, M. A.: Nosocomial infections in intensive care units: an over-view of their epidemiology, outcome, and prevention. New Horiz. 1 (1993) 162-171.
3. Burnie, J. P., Odds, F. C., Lee, W., Webster, C., Williams, J. D: Out-break of systemic Candida albicans infections in intensive care unit caused by cross infection. Br. Med. J. 290 (1985) 746-748.
4. Butler, K. M., Baker, C. J.: Candida: an increasingly important pathogen in the nursery. Pediatr. Clin. N. Am. 35 (1988) 543-563.
5. Doebbeling, B. N., Stanley, G., Sheetz, C. T., Pfaller, M. A., Houston, A. K., Annis, L., Li, N., Wenzel, R. P.: Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N. Engl. J. Med. 327 (1992) 88-93.
6. Vaudry, W. L., Tierney, A. J., Wenman, W. M.: Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J. Infect. Dis. 158 (1988) 1375-1379.
7. Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. E., Toison, J., Henderson, T., Martone, W. J.: Secular trends in nosocomial primary bloodstream infections in the United States. 1980-1989. National nosocomial infections surveillance system. Am. J. Med. 91 (1991) 86S-89S.
8. Broderick, A., Mori, M., Nettleman, M. D., Streed, S. A., Wenzel, R. P.: Nosocomial infections: validation of surveillance and computer modeling to identify patients at risk. Am. J. Epidemiol. 131 (1990) 734-742.
9. Pittet, D., Wenzel, R. P.: Nosocomial bloodstream infections. In: Wenzel, R. P. (ed.): Prevention and control of nosocomial infections. 2nd ed., Williams & Wilkins Co., Baltimore 1993, pp. 512-555.
10. Smith, R. L., Meixler, S. M., Simberkoff, M. S.: Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100 (1991) 164-167.
11. Sasse, K. C., Nauenberg, E., Long, A., Anton, B., Tucker, H. J., Hu, T. W.: Long-term survival after intensive care unit admission with sepsis. Crit. Care Med. 23 (1995) 1040-1047.
12. Wey, S. B., Mon, M., Pfaller, M. A., Woolson, R. F., Wenzel, R. P.: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149 (1989) 2349-2353.
13. Pittet, D., Monod, M., Suter, P. M., Frenk, E., Auckenthaler, R.: Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg. 220 (1994) 751-758.
14. Bross, J., Talbot, G. H., Maislin, G., Hurwitz, S., Strom, B. L.: Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am. J. Med. 87 (1989) 614-620.
15. LeGall, J. R., Lemeshow, S., Saulnier, F.: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270 (1993) 2957-2963.
16. Voss, A., Kluytmans, J. A. J. W., Koeleman, J. G. M., Spanjaard, L., Vandenbroucke-Grauls, C. M. J. E., Verbrugh, H. A., Vos, M. C., Weersink, A. J. L., Hoogkamp-Korstanje, J. A. A., Meis, J. F. G. M.: Occurence of Candida bloodstream infection in Dutch university hospitals between 1987 and 1995. Eur. J. Clin. Microbiol. Infect. Dis. (in press).
17. Powderly, W. G.: Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients [letter]. AIDS 6 (1992) 604-605.
18. Wingard, J. R.: Importance of Candida species other than C. albicans. as pathogens in oncology patients. Clin. Infect. Dis. 20 (1995) 115-125.
19. Kunova, A., Trupl, J., Spanik, S., Drgona, L., Sufliarsky, J., Lacka, J., Studena, V., Hlavacova, E., Studena, M., Kukuckova, E.: Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole. Chemotherapy 41 (1995) 39-44.
20. Wingard, J. R.: Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin. Infect. Dis. 19 Suppl. 1 (1994) S49-S53.
21. Verduyn Lunel, F. M., Voss, A., Neeleman, C., Meis, J. F. G. M.: Candidemie met Candida krusei bij een niet-neutropene intensive care patient. Ned. Tijdschr. Med. Microbiol. 4 (1996) 28-29.